Clinical Trials Directory

Trials / Unknown

UnknownNCT03240458

Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography

Screening For Diabetic Macular Edema Among Diabetic Patients In Assiut University Hospital Using Optical Coherence Tomography

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Diabetic macular edema is one of the major causes of visual impairment in diabetic retinopathy patients especially in the working age group. The problem is likely to increase in the future with statistics showing a growing number of the diabetic population especially in the Middle East . .

Detailed description

The worldwide prevalence of diabetic macular edema was reported as 6.81% among patients with diabetes. Other research reported that the 10-year incidence of diabetic macular edema was 14% in individuals with type 2 diabetes, and progression to diabetic macular edema occurred in 29% of individuals with type 1 diabetes over 25 years if left untreated . Although diabetic macular edema resolves spontaneously in about 33% to 35% of patients, it tends to be chronic in most patients..Diabetic macular edema can occur at any stage of diabetic retinopathy . The symptoms of diabetic macular range from slight visual blurring to complete blindness if left untreated . Optical coherence tomography is an objective non-invasive method for high-resolution cross-sectional imaging of the retina .

Conditions

Interventions

TypeNameDescription
DEVICEOptical Coherence Tomographyan objective non-invasive method for high-resolution cross-sectional imaging of the retina

Timeline

Start date
2017-08-10
Primary completion
2018-01-31
Completion
2018-02-28
First posted
2017-08-07
Last updated
2017-08-07

Source: ClinicalTrials.gov record NCT03240458. Inclusion in this directory is not an endorsement.